.Just five months after getting a $one hundred million IPO, Vast Bio is already laying off some empl...
.The initial stages of oncology R&D aren't except appealing new techniques, as well as Halda Ther...
.Psychopharmacology has drawn 3 articles concerning midstage scientific trial data assessing Lykos T...
.Avidity Biosciences pleased clients with phase 1/2 information in Duchenne muscular dystrophy (DMD)...
.Actinogen Medical's cortisol blocker has actually overlooked the main endpoint of a period 2 resear...
.Antibody-drug conjugates (ADCs) have actually gone to the center of lots of a billion-dollar biobuc...
.Asset manager TPG, which has actually supported biotechs such as Sionna Therapeutics and also Santa...
.Merck & Co.'s TIGIT plan has actually suffered another misfortune. Months after shuttering a sta...
.After a year described through pipe cuts, the departure of its CEO and also discharges, Exscientia ...
.Cullinan Therapeutics was wowed good enough with Harbour BioMed's bispecific immune activator that ...